| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyra Therapeutics, Inc. | Chief Medical Officer | Stock Options | 200K | Jan 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | Jan 30, 2024 | 1 | $0 | 4 | Feb 1, 2024 | Chief Medical Officer |
| LYRA | Lyra Therapeutics, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Chief Medical Officer |
| LYRA | Lyra Therapeutics, Inc. | Jul 11, 2022 | 1 | $0 | 4 | Jul 12, 2022 | Chief Medical Officer |
| LYRA | Lyra Therapeutics, Inc. | Jul 11, 2022 | 0 | $0 | 3 | Jul 12, 2022 | Chief Medical Officer |